Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Tekes.
Twitter and News
DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer
HOUSTON and HELSINKI, Nov. 13, 2018 /PRNewswire/ -- DNAtrix and Valo Therapeutics today announced an exclusive R&D collaboration to develop...
Members of the ImmunoVIroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.